Evidence map›Paper›PMID 39630888›Full record

ArticleScience advances2024

Boosting

Charlotte Bocquelet, Nathan Rougier, Huu-Nghia Le, Laurent Veyre, Chloe Thieuleux, Roberto Melzi, Armin Purea, Daniel Banks, James G Kempf, Quentin Stern and 2 more

Abstract read
In one paragraph

Article in Science advances, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. ACS omega · 2026
    Article
  2. Analytical chemistry · 2026
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Charlotte BocqueletUniversite Claude Bernard Lyon 1, CNRS, ENS Lyon, CRMN UMR 5082, 69100 Villeurbanne, France.ORCID 0009-0000-3833-5031
Nathan RougierUniversite Claude Bernard Lyon 1, CNRS, ENS Lyon, CRMN UMR 5082, 69100 Villeurbanne, France.
Huu-Nghia LeUniversite Claude Bernard Lyon 1, Institut de Chimie de Lyon, CP2M UMR 5128 CNRS-UCBL-CPE Lyon, 69616 Villeurbanne, France.
Laurent VeyreUniversite Claude Bernard Lyon 1, Institut de Chimie de Lyon, CP2M UMR 5128 CNRS-UCBL-CPE Lyon, 69616 Villeurbanne, France.ORCID 0009-0003-1004-2458
Chloe ThieuleuxUniversite Claude Bernard Lyon 1, Institut de Chimie de Lyon, CP2M UMR 5128 CNRS-UCBL-CPE Lyon, 69616 Villeurbanne, France.
Roberto MelziBruker Italia S.r.l., Viale V. Lancetti 43, 20158 Milano, Italy.ORCID 0009-0006-8180-6285
Armin PureaBruker BioSpin, 76287 Rheinstetten, Germany.
Daniel BanksBruker BioSpin, Billerica, MA 01821, USA.ORCID 0000-0003-2352-7457
James G KempfBruker BioSpin, Billerica, MA 01821, USA.ORCID 0000-0001-7135-4736
Quentin SternUniversite Claude Bernard Lyon 1, CNRS, ENS Lyon, CRMN UMR 5082, 69100 Villeurbanne, France.ORCID 0000-0002-8490-030X
Ewoud VaneeckhauteUniversite Claude Bernard Lyon 1, CNRS, ENS Lyon, CRMN UMR 5082, 69100 Villeurbanne, France.ORCID 0000-0003-2681-6246
Sami JanninUniversite Claude Bernard Lyon 1, CNRS, ENS Lyon, CRMN UMR 5082, 69100 Villeurbanne, France.ORCID 0000-0002-8877-4929

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sensitivity is often the Achilles' heel of liquid-state nuclear magnetic resonance (NMR) experiments. This problem is perhaps most pressing at the lowest fields (e.g., 80-MHz

Identifiers

PMID39630888
PMCPMC11616688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.